Format
Items per page
Sort by

Send to:

Choose Destination

Results: 15

Cited In for PubMed (Select 17288638)

1.

Comorbid substance use disorders in schizophrenia: a latent class approach.

Kerner B.

Psychiatry Res. 2015 Feb 28;225(3):395-401. doi: 10.1016/j.psychres.2014.12.006. Epub 2014 Dec 15.

PMID:
25576367
2.

The Cannabis Pathway to Non-Affective Psychosis may Reflect Less Neurobiological Vulnerability.

Løberg EM, Helle S, Nygård M, Berle JØ, Kroken RA, Johnsen E.

Front Psychiatry. 2014 Nov 18;5:159. doi: 10.3389/fpsyt.2014.00159. eCollection 2014.

3.

Long-term consequences of adolescent cannabinoid exposure in adult psychopathology.

Renard J, Krebs MO, Le Pen G, Jay TM.

Front Neurosci. 2014 Nov 10;8:361. doi: 10.3389/fnins.2014.00361. eCollection 2014. Review.

4.

The impact of cannabis use on clinical outcomes in recent onset psychosis.

Barrowclough C, Gregg L, Lobban F, Bucci S, Emsley R.

Schizophr Bull. 2015 Mar;41(2):382-90. doi: 10.1093/schbul/sbu095. Epub 2014 Jul 9.

PMID:
25011381
5.

Pathways from cannabis to psychosis: a review of the evidence.

Burns JK.

Front Psychiatry. 2013 Oct 14;4:128. doi: 10.3389/fpsyt.2013.00128. Review.

6.

Screening for substance use disorders in first-episode psychosis: implications for readmission.

Batalla A, Garcia-Rizo C, Castellví P, Fernandez-Egea E, Yücel M, Parellada E, Kirkpatrick B, Martin-Santos R, Bernardo M.

Schizophr Res. 2013 May;146(1-3):125-31. doi: 10.1016/j.schres.2013.02.031. Epub 2013 Mar 19.

7.

Susceptibility of the adolescent brain to cannabinoids: long-term hippocampal effects and relevance to schizophrenia.

Gleason KA, Birnbaum SG, Shukla A, Ghose S.

Transl Psychiatry. 2012 Nov 27;2:e199. doi: 10.1038/tp.2012.122.

8.

Cannabis use and cognitive dysfunction.

Shrivastava A, Johnston M, Tsuang M.

Indian J Psychiatry. 2011 Jul;53(3):187-91. doi: 10.4103/0019-5545.86796. No abstract available.

9.

Does change in cannabis use in established psychosis affect clinical outcome?

Barrowclough C, Emsley R, Eisner E, Beardmore R, Wykes T.

Schizophr Bull. 2013 Mar;39(2):339-48. doi: 10.1093/schbul/sbr152. Epub 2011 Oct 29.

10.

Cannabis use disorders in schizophrenia: effects on cognition and symptoms.

DeRosse P, Kaplan A, Burdick KE, Lencz T, Malhotra AK.

Schizophr Res. 2010 Jul;120(1-3):95-100. doi: 10.1016/j.schres.2010.04.007. Epub 2010 May 18.

11.

Cannabis use and the course of schizophrenia: 10-year follow-up after first hospitalization.

Foti DJ, Kotov R, Guey LT, Bromet EJ.

Am J Psychiatry. 2010 Aug;167(8):987-93. doi: 10.1176/appi.ajp.2010.09020189. Epub 2010 May 17.

12.

Cannabis use and cognition in schizophrenia.

Løberg EM, Hugdahl K.

Front Hum Neurosci. 2009 Nov 24;3:53. doi: 10.3389/neuro.09.053.2009. eCollection 2009.

13.

Should burden of disease estimates include cannabis use as a risk factor for psychosis?

Degenhardt L, Hall WD, Lynskey M, McGrath J, McLaren J, Calabria B, Whiteford H, Vos T.

PLoS Med. 2009 Sep;6(9):e1000133. doi: 10.1371/journal.pmed.1000133. Epub 2009 Sep 29. No abstract available.

14.

Cannabis and psychosis/schizophrenia: human studies.

D'Souza DC, Sewell RA, Ranganathan M.

Eur Arch Psychiatry Clin Neurosci. 2009 Oct;259(7):413-31. doi: 10.1007/s00406-009-0024-2. Epub 2009 Jul 16. Review.

15.

Cannabis use and the risk of developing a psychotic disorder.

Hall W, Degenhardt L.

World Psychiatry. 2008;7(2):68-71.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk